This process activates a TLR4-dependent pathway and the CXCL1-CXCR2 axis, leading to the accumulation of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs), which facilitate immune evasion and promote tumor progression. The gene discussed is CXCR2; the disease is neoplasm.